Egetis Therapeutics
Develops and commercializes treatments for serious and rare diseases.
EGTX | ST
Overview
Corporate Details
- ISIN(s):
- SE0003815604
- LEI:
- 549300RZCKGWRUBPMY22
- Country:
- Sweden
- Address:
- Klara Norra Kyrkogata 26, 111 22 Stockholm
- Website:
- https://www.egetis.com/
- Sector:
- Manufacturing
Description
Egetis Therapeutics is an innovative and integrated pharmaceutical company focused on developing and commercializing treatments for serious and rare diseases with significant unmet medical needs. The company's strategy centers on advancing drug candidates through late-stage clinical development to market approval. Its primary asset, Emcitate (tiratricol), is a first-in-class drug candidate in late-stage development for the treatment of Monocarboxylate Transporter 8 (MCT8) deficiency, a rare congenital disorder of thyroid hormone transport.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-03-29 18:38 |
NOTICE OF ANNUAL GENERAL MEETING IN EGETIS THERAPEUTICS AB (PUBL)
|
English | 120.4 KB | ||
| 2024-02-22 07:00 | Swedish | 4.9 MB | |||
| 2024-02-22 07:00 | English | 4.4 MB | |||
| 2023-11-10 08:37 |
Egetis announces exclusive license agreement with Fujimoto to develop and comme…
|
English | 76.8 KB | ||
| 2023-11-10 08:37 |
Egetis ingår exklusivt licensavtal med Fujimoto för att utveckla och kommersial…
|
Swedish | 77.8 KB | ||
| 2023-11-08 07:00 | Swedish | 4.0 MB | |||
| 2023-11-08 07:00 | English | 3.6 MB | |||
| 2023-11-07 08:00 |
Egetis Therapeutics har beslutat om riktade emissioner av teckningsoptioner och…
|
Swedish | 55.3 KB | ||
| 2023-11-07 08:00 |
Egetis Therapeutics has resolved on directed issues of warrants and a convertib…
|
English | 54.0 KB | ||
| 2023-11-02 15:11 | English | 34.1 KB | |||
| 2023-11-01 09:13 | English | 34.1 KB | |||
| 2023-11-01 07:00 |
Egetis valberedning utsedd inför årsstämman 2024
|
Swedish | 57.3 KB | ||
| 2023-11-01 07:00 |
Egetis’ Nomination Committee for the 2024 Annual General Meeting
|
English | 57.7 KB | ||
| 2023-10-31 15:45 |
Ändring av antalet aktier och röster i Egetis Therapeutics
|
Swedish | 62.2 KB | ||
| 2023-10-31 15:45 |
Change in the number of shares and votes in Egetis Therapeutics
|
English | 57.0 KB |
Automate Your Workflow. Get a real-time feed of all Egetis Therapeutics filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Egetis Therapeutics
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Egetis Therapeutics via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-01-09 | Yilmaz Mahshid | Other | Sell | 39,753 | 268,332.75 SEK |
| 2025-01-08 | Yilmaz Mahshid | Other | Sell | 98,567 | 653,499.21 SEK |
| 2025-01-07 | Yilmaz Mahshid | Other | Sell | 74,769 | 507,681.51 SEK |
| 2024-10-07 | Nicklas Westerholm | Other | Buy | 10,142 | 43,103.50 SEK |
| 2024-10-07 | Yilmaz Mahshid | Other | Buy | 10,000 | 42,250.00 SEK |
| 2023-07-07 | Henrik Krook | Other | Buy | 33,594 | 133,704.12 SEK |
| 2023-07-06 | Christian Sonesson | Other | Buy | 3,616 | 14,391.68 SEK |
| 2023-07-06 | Christian Sonesson | Other | Buy | 2,000 | 7,920.00 SEK |
| 2023-07-05 | Christian Sonesson | Other | Buy | 1,384 | 5,452.96 SEK |
| 2023-07-04 | Nicklas Westerholm | Other | Buy | 15,350 | 60,632.50 SEK |
Peer Companies
